Combination therapy with CDK4/6i and ET is the treatment of choice for patients with luminal HER2-negative ABC without VC features for postmenopausal and premenopausal patients (provided luteinizing hormone-releasing hormone (LHRH) agonists are administered or ovariectomy is performed) [2,18]. Here, CDK4 is linked to aneurysmal bone cyst.